Download:
pdf |
pdfOMB Number: 0920-0612
Expiration Date: 12/31/2018
WISEWOMAN
Program
MDE Manual for DP18-1816
Edition 18.1
Item 1a: StFIPS
State/Tribal FIPS Code
This variable indicates the FIPS or tribal program code for the state or tribe where the administration
of the program is located.
SOURCE
National FIPS Code List
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
01 Alabama (AL)
Program administration located in Alabama
06 California (CA)
Program administration located in California
08 Colorado (CO)
Program administration located in Colorado
09 Connecticut (CT)
Program administration located in Connecticut
17 Illinois (IL)
Program administration located in Illinois
18 Indiana (IN)
Program administration located in Indiana
19 Iowa (IA)
Program administration located in Iowa
26 Michigan (MI)
Program administration located in Michigan
29 Missouri (MO)
Program administration located in Missouri
31 Nebraska (NE)
Program administration located in Nebraska
37 North Carolina (NC)
Program administration located in North Carolina
41 Oregon (OR)
Program administration located in Oregon
42 Pennsylvania (PA)
Program administration located in Pennsylvania
44 Rhode Island (RI)
Program administration located in Rhode Island
45 South Carolina (SC)
Program administration located in South Carolina
49 Utah (UT)
Program administration located in Utah
50 Vermont (VT)
Program administration located in Vermont
54 West Virginia (WV)
Program administration located in West Virginia
55 Wisconsin (WI)
Program administration located in Wisconsin
85 Southeast Alaska Regional Health
Consortium (SEARHC)
Program administration located within the tribal
area of SEARHC
92 Southcentral Foundation (SCF)
Program administration located within the tribal
area of SCF
ANALYSIS AND USE
To calculate the number of women screened by each state or tribal program
To assess the reach of the WISEWOMAN Program nationally and within a particular state or tribe
2
Item 1b: HdANSI
ANSI Geographic Code (Provider)
This indicates the ANSI geographic code of the provider that conducts the WISEWOMAN screening
office visit.
SOURCE
National ANSI Code List, Census Bureau
DENOMINATOR
POPULATION
The denominator includes all valid screenings
VALUES AND
DESCRIPTION
ANSI Geographic Code
ANALYSIS AND USE
To assess whether programs and specific providers are meeting screening goals in targeted
geographic areas
To identify geographic areas where women have access to the WISEWOMAN Program
To provide information for GIS analysis
To assist in identifying areas where there may be potential transportation barriers to accessing
WISEWOMAN services
Five-digit (character) value representing the geographic area of the
provider that conducts the screening office visit
3
Item 1c: EnrollSiteID
Enrollment Site ID
This variable indicates the site of a woman’s enrollment into the WISEWOMAN Program.
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Enrollment Site ID
ANALYSIS AND USE
To identify sites where outreach and enrollment are occurring
To identify sites where the Program is being administered and participants are tracked
To track the number of WISEWOMAN participants enrolled at each WISEWOMAN enrollment site
Valid five-digit ZIP code for the person administering enrollment of
participant
4
Item 1d: ScreenSiteID
Screening Site ID
This variable indicates the site where a woman received her WISEWOMAN screening.
SOURCE
National Provider Identifier
DENOMINATOR
POPULATION
The denominator includes all valid screenings
VALUES AND
DESCRIPTION
Screening Site ID
ANALYSIS AND USE
To identify the geographic locations of sites providing screening services to participants
To track the number of WISEWOMAN participants screened at each WISEWOMAN screening site
To describe differences in participant demographics or other characteristics by screening site
To provide information for GIS analysis
To identify the number of screening providers in a given geographic area
To identify provider pool for assessment of health systems and providers that use clinical systems of
care successful in blood pressure control
Value representing a National Provider Identifier for the provider who
conducts the screening office visit
5
Item 2a: TimePer
Time Period of Screening
This variable indicates the 6-month time period of the baseline screening for the participant.
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes all valid baseline screenings
VALUES AND
DESCRIPTION
1 6-month period 1
Baseline screening took place between 10/01/18 and 03/31/19
2 6-month period 2
Baseline screening took place between 04/01/19 and 09/30/19
3 6-month period 1
Baseline screening took place between 10/01/19 and 03/31/20
4 6-month period 2
Baseline screening took place between 04/01/20 and 09/30/20
5 6-month period 1
Baseline screening took place between 10/01/20 and 03/31/21
6 6-month period 2
Baseline screening took place between 04/01/21 and 09/30/21
7 6-month period 1
Baseline screening took place between 10/01/21 and 03/31/21
8 6-month period 2
Baseline screening took place between 04/01/22 and 09/30/22
9 6-month period 1
Baseline screening took place between 10/01/22 and 03/31/23
0 6-month period 2
Baseline screening took place between 04/01/23 and 09/30/23
ANALYSIS AND USE
To track participants over the course of the cooperative agreement by their baseline screenings
To track the number of unique participants programs have screened
6
Item 2b: NScreen
Number of Screening Cycles Received by the Participant
This variable indicates the total number of screening cycles that the participant has received since
the beginning of the cooperative agreement.
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Number of Visits
ANALYSIS AND USE
To track the number of screenings/rescreenings/follow-up assessments after a completed LSP/HC
that the participant has received
Value representing the number of screening cycles that the participant
has received since the beginning of the cooperative agreement (includes
current screening cycle).
Any values outside 01 to 08 will be flagged for a quality check
7
Item 2c: Type
Type of Screening Visit
This variable indicates whether the record represents a baseline screening visit, a rescreening visit,
or a post-Lifestyle Program (LSP)/Health Coaching (HC) follow-up assessment.
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes all valid screenings
VALUES AND
1 Screening
Record represents a baseline screening visit
DESCRIPTION
2 Rescreening
Record represents a rescreening visit
3 Follow-up assessment –
LSP/HC complete
Record represents a post-LSP/HC follow-up assessment with a
complete LSP/HC
4 Follow-up assessment –
LSP/HC incomplete
Record represents a post-LSP/HC follow-up assessment with an
incomplete LSP/HC
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To assess the number of unique women served by the WISEWOMAN Program
To track participants screening values over time
To link baseline screenings with rescreenings
To assess participants progress after completion of an LSP/HC
8
Item 2d: Navigation
Were the navigation services paid for by NBCCEDP funds, WISEWOMAN funds, Indian
Health Services/ Tribal funds, or other funds?
This variable indicates the funding source for navigation services for participants receive health
behavior support services, but whose cardiovascular screenings are not funded by WISEWOMAN.
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes all valid screenings
VALUES AND
DESCRIPTION
1 NBCCEDP funds
Participant received navigation services paid by NBCCEDP funds
2 WISEWOMAN funds
Participant received navigation services paid by WISEWOMAN funds
3 Indian Health
Service/Tribal funds
Participant received navigation services paid by Indian Health Services/
Tribal funds
4 Other funds
Participant received navigation services paid by other funds
5 Not Applicable
Not applicable because participant did not receive navigated services
ANALYSIS AND USE
To track participants served through the federally-funded WISEWOMAN program
9
Item 3a: EncodeID
Unique Participant ID Number
This variable indicates a woman’s unique identification number.
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Unique Participant ID
Number
ANALYSIS AND USE
To assess the number of unique women served by the WISEWOMAN Program
To track participants over time
To link baseline screenings with rescreenings
To link screenings with risk reduction counseling, lifestyle programs, health coaching, and
community-based resource referrals
Value representing the unique identifier for a participant
10
Item 3b: ResANSI
ANSI Geographic Code of Residence
This variable indicates the ANSI geographic code of residence of the WISEWOMAN participant.
SOURCE
National ANSI Code List
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
ANSI Geographic Code
ANALYSIS AND USE
To assess whether programs are meeting screening goals in targeted geographic areas
To identify the reach of the WISEWOMAN Program
To assist in identifying areas where there may be potential transportation barriers to accessing
WISEWOMAN services
Value representing the participant’s geographic area of residence
11
Item 3c: ZIP
ZIP Code of Residence
This variable indicates the participant’s ZIP code of residence.
SOURCE
National ZIP Code List
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
ZIP Code of Residence
Valid five-digit (character) ZIP code
99999
No ZIP code recorded
This value will be flagged as an error
ANALYSIS AND USE
To assess whether programs are meeting screening goals in targeted geographic areas
To identify the reach of the WISEWOMAN Program
To identify participant county of residence outside program state boundaries
12
Item 3d: MYB
Month and Year of Birth
This variable indicates the participant’s month and year of birth.
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Month and Year of Birth
ANALYSIS AND USE
To estimate the age of the participant; age will be calculated using the month and year of birth and
office visit date (BPDate)
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score
To assess whether the participants are within the Program’s priority age group
Month and Year of Birth in MMCCYY format
Example: September 01, 1965 = 091965
13
Item 3e: Latino
Hispanic or Latino Origin
This variable indicates whether the participant is of Hispanic or Latino origin.
SOURCE
United States Office of Management and Budget Guidelines
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
1 Yes
Participant reports that she is of Hispanic or Latino origin
2 No
Participant reports that she is not of Hispanic or Latino origin
7 Unknown
Participant is unsure whether she is of Hispanic or Latino origin
9 No answer recorded
Participant has not reported whether she is of Hispanic or Latino origin
This value will be flagged as an error
ANALYSIS AND USE
To assess the race/ethnicity of WISEWOMAN participants
To analyze screening, lifestyle programs, and other variables by ethnicity
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score
14
Item 3f: Race1
Race: First Race
This variable indicates a race with which the participant identifies.
SOURCE
United States Census Bureau; United States Office of Management and Budget Guidelines
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
1 White
Participant identifies White as a race
2 Black or African American
Participant identifies Black or African American as a race
3 Asian
Participant identifies Asian as a race
4 Native Hawaiian or Other
Pacific Islander
Participant identifies Native Hawaiian or Other Pacific Islander as a
race
5 American Indian or Alaska
Native
Participant identifies American Indian or Alaska Native as a race
7 Unknown
Participant does not know her race or does not identify with any of
the races listed above
If a participant is Hispanic and does not identify a race, this code
should be used
9 No answer recorded
Race information is missing for the participant
Any race information gathered should be entered beginning with the
Race1 field
See cross edits related to this value
ANALYSIS AND
USE
To assess the race/ethnicity of WISEWOMAN participants
To understand and analyze screening, lifestyle programs, and other variables by race
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score
15
Item 3g: Race2
Race: Second Race
This variable indicates a race with which the participant identifies in cases where a participant is
multiracial.
SOURCE
United States Census Bureau; United States Office of Management and Budget Guidelines
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
1 White
Participant identifies White as a race
Participant who has identified two or more races can have this value
2 Black or African
American
Participant identifies Black or African American as a race
Participant who has identified two or more races can have this value
3 Asian
Participant identifies Asian as a race
Participant who has identified two or more races can have this value
4 Native Hawaiian or
Other Pacific Islander
Participant identifies Native Hawaiian or Other Pacific Islander as a
race
Participant who has identified two or more races can have this value
5 American Indian or
Alaska Native
Participant identifies American Indian or Alaska Native as a race
Participant who has identified two or more races can have this value
7 Unknown
Participant does not know her race or does not identify with any of
the races listed above
9 No answer recorded
If race information is missing for Race2
Participant has not identified any race
Participant has identified one race and does not identify other races
If a participant does not identify a second race, ‘9 No answer
recorded’ should be used for this field and all subsequent race fields
ANALYSIS AND USE
To assess the race/ethnicity of WISEWOMAN participants
To understand and analyze screening, lifestyle programs, and other variables by race
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score
16
Item 3h: Education
Education (highest grade completed)
This variable indicates the highest grade the participant completed.
SOURCE
CDC Behavioral Risk Factor Surveillance System
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
1 <9th grade
Participant reports that she did not attend high school
2 Some high school
Participant reports she attended high school, but did not graduate
3 High school graduate
or equivalent
Participant reports that she graduated from high school or has the
equivalent of a high school diploma, and she did not attend any
college or higher education
4 Some college or higher
Participant reports that she attended one or more years of college
and/or graduate school (e.g., college graduate, graduate degree)
7 Don’t know/Not sure
Participant reports that she does not know the highest grade she
completed
This value will be flagged as a quality check
8 Don’t want to answer
Participant does not want to answer the highest grade she completed
This value will be flagged as a quality check
9 No answer recorded
Education information is missing for the participant
This value will be flagged as an error
ANALYSIS AND USE
To assess the educational attainment of women in the WISEWOMAN population
To understand screening, lifestyle programs , and other variables by education status
To help determine the literacy level needed for materials developed for recruitment, risk reduction
counseling, lifestyle programs, health coaching, and community-based resources
To assist in characterizing the population reached by the WISEWOMAN Program
17
Item 3i: Language
What is the primary language spoken in your home?
This variable indicates the primary language spoken in the participant’s home.
SOURCE
National Survey of Children’s Health
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
01 English
Participant identifies English as the primary language spoken in her
home
02 Spanish
Participant identifies Spanish as the primary language spoken in her
home
03 Arabic
Participant identifies Arabic as the primary language spoken in her
home
04 Chinese
Participant identifies Chinese as the primary language spoken in her
home
05 French
Participant identifies French as the primary language spoken in her
home
06 Italian
Participant identifies Italian as the primary language spoken in her
home
07 Japanese
Participant identifies Japanese as the primary language spoken in
her home
08 Korean
Participant identifies Korean as the primary language spoken in her
home
09 Polish
Participant identifies Polish as the primary language spoken in her
home
10 Russian
Participant identifies Russian as the primary language spoken in her
home
11 Tagalog
Participant identifies Tagalog as the primary language spoken in her
home
12 Vietnamese
Participant identifies Vietnamese as the primary language spoken in
her home
13 Creole
Participant identifies Creole as the primary language spoken in her
home
14 Portuguese
Participant identifies Portuguese as the primary language spoken in
her home
15 Hmong
Participant identifies Hmong as the primary language spoken in her
home
16 Other Language
Participant identifies another language as the primary language
spoken in her home (write-in response)
88 Don’t want to answer
Participant does not want to answer the primary language spoken in
her home
This value will be flagged as a quality check
99 No answer recorded
Primary language information is missing for the participant
This value will be flagged as an error
ANALYSIS AND USE
To assess the primary language of women in the WISEWOMAN population
To provide context to potential the health literacy issues
To assist in characterizing the population reached by the WISEWOMAN Program
18
Item 4a: SRC
Which of the following conditions do you have:
i.
Hypertenion
ii.
High cholesterol
iii.
Diabetes (Type 1 or Type 2)
This variable indicates whether the participant has hypertension, high cholesterol, and/ or diabetes.
SOURCE
American Heart Association
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
(CODE FOR EACH
CONDITION)
1 Yes
Participant has the condition
2 No
Participant does not have the condition
7 Don’t know/Not sure
Participant does not know whether she has condition
This value will be flagged as a quality check
8 Don’t want to answer
Participant does not want to answer whether she has the condition
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of hypertension, high cholesterol, and diabetes that have been
previously diagnosed as opposed to newly detected cases among the WISEWOMAN population
To assess control of and improvements in blood pressure, cholesterol, and diabetes for newly and
previously diagnosed women
To provide data element required to determine participant’s cardiovascular risk score
19
Item 4b: SRHA
Have you had any of the following:
i.
Stroke/ TIA
ii.
Heart attack
iii.
Coronary heart disease
iv.
Heart failure
v.
Vascular disease (peripheral arterial disease)
vi.
Congenital heart disease and defects
This variable indicates whether the participant has ever been diagnosed by a healthcare provider as
having stroke/ TIA, heart attack, coronary heart disease, heart failure, vascular disease (peripheral
arterial disease), and/ or congenital heart disease and defects.
SOURCE
American Heart Association
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
(CODE FOR EACH
CONDITION)
1 Yes
Participant has been diagnosed by a healthcare provider as having
the condition
2 No
Participant has never been diagnosed by a healthcare provider as
having each condition
7 Don’t know/Not sure
Participant does not know whether she has been diagnosed by a
healthcare provider as having the condition
This value will be flagged as a quality check
8 Don’t want to answer
Participant does not want to answer whether she has been
diagnosed by a healthcare provider as the condition
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To understand the history of cardiovascular disease among individual participants and the overall
WISEWOMAN population
To assess the number of participants who have been previously diagnosed as having
cardiovascular disease
To provide data element required to determine participant’s cardiovascular risk score
20
Item 5a: Meds
Was medication prescribed to lower:
i.
Blood pressure
ii.
Cholesterol (Statin)
iii.
Cholesterol (other prescribed medication)
iv.
Blood sugar
This variable indicates whether the participant takes medication to lower her blood pressure,
cholesterol, and/or blood sugar.
SOURCE
American Heart Association
DENOMINATOR
POPULATION
The denominator includes WISEWOMAN participants with hypertension (high blood pressure), high
cholesterol, or diabetes or participants who were previously diagnosed with hypertension (high blood
pressure), high cholesterol, or diabetes
VALUES AND
DESCRIPTION
(CODE FOR EACH
CONDITION)
1 Yes
Participant is taking medication for the condition
2 No
Participant is not taking medication for the condition
5 Not Applicable
This question is not applicable for the patient because she has never
been diagnosed with for the condition, either because she does not
have for the condition (as assessed with a measurement at screening/
rescreening) or because she reports that she has never been
diagnosed with for the condition (as assessed with self-report at
screening/ rescreening).
7 Don’t know/Not sure
Participant does not know whether she is taking medication for the
condition
This value will be flagged as a quality check
8 Don’t want to answer
Participant does not want to answer whether she is taking medication
for the condition
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of hypertension, high cholesterol, and diabetes that have been
previously diagnosed as opposed to newly detected cases among the WISEWOMAN population
To assess the control and management of blood pressure, cholesterol, and diabetes among
participants who have hypertension, high cholesterol, or diabetes
To assist in assessment of adherence to medication for hypertension, high cholesterol, and diabetes
To provide data element required to determine participant’s cardiovascular risk score
21
Item 5b: Aspirin
Are you taking aspirin daily to help prevent a heart attack or stroke?
This variable indicates whether the participant is taking aspirin daily to help prevent a heart attack or
stroke.
SOURCE
American College of Cardiology
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
1 Yes
Participant is taking aspirin daily to help prevent a heart attack or
stroke
2 No
Participant is not taking aspirin daily to help prevent a heart attack or
stroke
7 Don’t know/Not sure
Participant does not know whether she is taking aspirin daily to help
prevent a heart attack or stroke
This value will be flagged as a quality check
8 Don’t want to answer
Participant does not want to answer whether she is taking aspirin
daily to help prevent a heart attack or stroke
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
22
Item 5c: MedAdhere
During the past 7 days, how many days didyou take prescribed mediation for the
following conditions:
i.
High blood pressure (0 – 7 days)
ii.
High Cholesterol (0 – 7 days)
iii.
High blood sugar (0 – 7 days)
This variable indicates the number of days out of the past 7 days, including the day of
the screening, that the participant took prescribed medication to lower her blood
pressure, cholesterol, and/or blood sugar.
SOURCE
Adapted from National Survey of Children’s Health
DENOMINATOR POPULATION
The denominator includes WISEWOMAN participants taking medication to lower blood
pressure, cholesterol, or blood sugar
VALUES AND DESCRIPTION
(CODE FOR EACH CONDITION)
Number of days (01-07)
A numeric value indicating the number of days out of the
past 7 days, including the day of the screening, that the
participant took prescribed medication for the condition
Any value outside the valid range (01 – 07) will be
considered an error
00 None
In the past 7 days, including the day of the screening, the
participant did not take prescribed medication for the
condition
55 Not Applicable
This question is not applicable for the patient because she
has never been diagnosed with high cholesterol and/or has
indicated that she does not take medication for high
cholesterol
77 Don’t know/Not sure
Participant is not sure whether she took prescribed
medication to lower her cholesterol during the past 7 days
including the day of the screening
This value will be flagged as a quality check
88 Don’t want to answer
Participant did not want to answer whether she took
prescribed medication for the condition during the past 7
days, including the day of the screening
This value will be flagged as a quality check
99 Not applicable
This question is not applicable for the patient because she
has never been diagnosed with the condition (high blood
pressure, high cholesterol, or high blood sugar) and/or has
indicated that she does not take medication for the
condition
ANALYSIS AND USE
To facilitate assessment of adherence to medication prescribed for high blood pressure,
high cholesterol, and diabetes
To assist in determining management and control for high blood pressure, high
cholesterol, and diabetes
23
Item 5d: Monitored
After being prescribed medication, on what date(s) did the participant have her blood
pressure re-measured either by a healthcare provider, or with another community resource?
This variable indicates the date when blood pressure is re-measured for a participant who is
prescribed blood pressure medication.
SOURCE
WISEWOMAN-specific variable for blood pressure follow-up
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants taking medication to lower blood pressure
VALUES AND
DESCRIPTION
Blood Pressure
Monitoring Dates
ANALYSIS AND USE
To assist in determining management and control for high blood pressure
Valid date in MMDDCCYY format
Date when blood pressure is re-measured by a health care provider
or another community resource
Example: September 10, 2013 = 09102013
24
Item 6a: BPHome
Do you measure your blood pressure at home or using other calibrated sources?
This variable indicates whether the participant monitors her blood pressure at home or using other
calibrated sources (select all response options that apply).
SOURCE
HealthStyles Survey
DENOMINATOR
POPULATION
The denominator includes WISEWOMAN participants with high blood pressure or previously
diagnosed with hypertension (high blood pressure)
VALUES AND
DESCRIPTION
1 Yes
Participant reports that she measures her blood pressure at home or
using other calibrated sources
2 No – Was never told to
measure her blood
pressure
Participant reports that she does not measure her blood pressure at
home or using other calibrated sources because she was never told
she should measure her blood pressure
3 No – Doesn’t know how
to measure her blood
pressure
Participant reports that she does not measure her blood pressure at
home or using other calibrated sources because she does not know
how to measure her blood pressure
4 No – Doesn’t have
equipment to measure
her blood pressure
Participant reports that she does not measure her blood pressure at
home or using other calibrated sources because she does not have
access to the required equipment to measure her blood pressure
5 Not Applicable
This question is not applicable for the patient because she has never
been diagnosed with hypertension (high blood pressure)
7 Don’t know/Not
sure/Other
Participant is not sure whether she measures her blood pressure at
home or using other calibrated sources or provides some other
reason for why she does not measure her blood pressure at home
(for example, participant chooses not to measure her blood at home)
This value will be flagged as a quality check
8 Don’t want to answer
Participant did not want to answer whether she measures her blood
pressure at home or using other calibrated sources
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine self-control and management of hypertension (high blood pressure)
25
Item 6b: BPFreq
How often do you measure your blood pressure at home or using other calibrated sources?
This variable indicates how frequently the participant measures her blood pressure at home or using
other calibrated sources.
SOURCE
HealthStyles Survey
DENOMINATOR
POPULATION
The denominator includes WISEWOMAN participants with high blood pressure or previously
diagnosed with hypertension (high blood pressure)
VALUES AND
DESCRIPTION
1 Multiple times per day
Participant measures her blood pressure at home or using other
calibrated sources multiple times per day
2 Daily
Participant measures her blood pressure at home or using other
calibrated sources once per day
3 A few times per week
Participant measures her blood pressure at home or using other
calibrated sources a few times per week
4 Weekly
Participant measures her blood pressure at home or using other
calibrated sources once per week
5 Monthly
Participant measures her blood pressure at home or using other
calibrated sources once per month
6 Not Applicable
This question is not applicable for the patient because she has never
been diagnosed with hypertension (high blood pressure) or does not
monitor her blood pressure at home or using other calibrated sources
7 Don’t know/Not
sure/Other
Participant is not sure how frequently she measures her blood
pressure at home or using other calibrated sources
This value will be flagged as a quality check
8 Don’t want to answer
Participant did not want to answer how frequently she measures her
blood pressure at home or using other calibrated sources
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine self-control and management of hypertension (high blood pressure)
26
Item 6c: BPSend
Do you regularly share blood pressure readings with a health care provider for feedback?
This variable indicates whether the participant shares blood pressure readings taken at home or
using other calibrated sources with a health care provider for feedback almost every time she sees
her provider.
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes WISEWOMAN participants with high blood pressure or previously
diagnosed with hypertension (high blood pressure)
VALUES AND
DESCRIPTION
1 Yes
Participant reports that she shares blood pressure readings taken at
home or using other calibrated sources with a health care provider for
feedback almost every time she sees her provider
2 No
Participant reports that she does not share blood pressure readings
taken at home or using other calibrated sources with a health care
provider for feedback
5 Not Applicable
This question is not applicable for the patient because she has never
been diagnosed with hypertension (high blood pressure) or does not
monitor her blood pressure at home or using other calibrated sources
7 Don’t know/Not
sure/Other
Participant is not sure whether she shares blood pressure readings
taken at home or using other calibrated sources with a health care
provider for feedback
This value will be flagged as a quality check
8 Don’t want to answer
Participant did not want to answer whether she shares blood
pressure readings taken at home or using other calibrated sources
with a health care provider for feedback
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine self-control and management of hypertension (high blood pressure)
To determine whether blood pressure monitoring results are shared with a health care provider for
monitoring of progress
27
Item 7a: FruitVeg
How many cups of fruits and vegetables do you eat in an average day?
This variable indicates the amount of fruit and vegetables the participant consumes in an average
day.
SOURCE
American Heart Association
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Number of cups
Two-digit (numeric) value representing the number of cups of fruit
and vegetables the participant consumes in an average day
Any value outside the valid range (01 -65) will be considered an error
Example: 2 cups = 02
00 None
Participant does not consume fruit or vegetables in an average day
88 Don’t want to answer
Participant does not want to answer how many cups of fruit and
vegetables she consumes in an average day
This value will be flagged as a quality check
99 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score
28
Item 7b: Fish
Do you eat fish at least two times a week?
This variable indicates whether the participant consumes two servings or more of fish weekly.
SOURCE
American Heart Association
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
1 Yes
Participant consumes two servings or more of fish weekly
2 No
Participant does not consume two servings or more of fish weekly
8 Don’t want to answer
Participant does not want to answer whether she consumes two
servings or more of fish weekly
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score
29
Item 7c: Grains
Thinking about all the servings of grain products you eat in a typical day, how many are
whole grains?
This variable indicates the relative amount of whole grains the participant consumes compared to
the total amount of grains consumed in a typical day.
SOURCE
United State’s Department of Agriculture
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
1 Less than half
Less than half of servings of grain products consumed in a typical
day are whole grains
2 About half
About half of servings of grain products consumed in a typical day
are whole grains
3 More than half
More than half of servings of grain products consumed in a typical
day are whole grains
8 Don’t want to answer
Participant does not want to answer how many servings of grain
products consumed in a typical day are whole grains
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score
30
Item 7d: Sugar
Do you drink less than 36 ounces (450 calories) of sugar sweetened beverages weekly?
This variable indicates whether the participant drinks less than 36 ounces (450 calories) of sugar
sweetened beverages weekly.
SOURCE
American Heart Association
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
1 Yes
Participant consumes less than 36 ounces (450 calories) of
beverages with added sugars in an average week
2 No
Participant consumes 36 ounces or more (450 calories or more) of
beverages with added sugars in an average week
8 Don’t want to answer
Participant does not want to answer whether she consumes less than
36 ounces (450 calories) or more of beverages with added sugars in
an average week
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score
31
Item 7e: SaltWatch
Are you currently watching or reducing your sodium or salt intake?
This variable indicates whether the participant is currently watching or reducing her sodium or salt
intake.
SOURCE
CDC Behavioral Risk Factor Surveillance System
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
1 Yes
Participant is currently watching or reducing her sodium or salt intake
2 No
Participant is not currently watching or reducing her sodium or salt
intake
8 Don’t want to answer
Participant does not want to answer whether she is currently
watching or reducing her sodium or salt intake
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
32
Item 7f: AlcDay
In the past 7 days, how often do you have a drink containing alcohol?
This variable indicates the number of days during the past 7 days that a participant had a drink
containing alcohol.
SOURCE
Alcohol Use Disorders Identification Test
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Number of days
A two-digit (numeric) value representing the number of days during
the past 7 days that the participant consumed a drink contained
alcohol
Example: 4 days = 04
00 None
Participant has not consumed any drinks containing alcohol during
the past 7 days
88 Don’t want to answer
Participant does not want to answer how many days during the past 7
days she has consumed drinks containing alcohol
This value will be flagged as a quality check
999 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
33
Item 7g: AlcFreq
How many alcoholic drinks, on average, do you consume during a day you drink?
This variable indicates the average number of alcoholic drinks consumed during a day.
SOURCE
Alcohol Use Disorders Identification Test
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Number of drinks
A numeric value indicating the average number of alcoholic
drinks consumed during a day when the participant is drinking
alcohol
Any value outside the valid range (00 – 07) will be considered
an error
00 None
The participant does not consume any alcoholic drinks
88 Don’t want to answer
Participant did not want to answer the average number of
alcoholic drinks she consumes during a day when she is
drinking alcohol
This value will be flagged as a quality check
99 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
34
Item 8a: PA
How many minutes of physical activity (exercise) do you get in a week?
This variable indicates the amount of physical activity the participant gets during an average week.
SOURCE
American Heart Association Life’s
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Number of minutes
A four-digit (numeric) value representing the minutes of physical
activity the participant gets during an average week
Any value outside the valid range (0010 – 1700) will be considered a
quality check
Example: 30 minutes = 0030
If the number of minutes of physical activity exceeds 1700 minutes,
PA should be coded as 1700 and the number of minutes of physical
activity should be documented using the Validation of Data form. See
Appendix B for the procedure for validating out-of-range values.
0000 None
Participant does not get any physical activity during an average week
8888 Don’t want to
answer
Participant does not want to answer how much physical activity she
gets during an average week
This value will be flagged as a quality check
9999 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score
35
Item 9a: Smoker
Do you smoke? Includes cigarettes, pipes, or cigars (smoked tobacco in any form)
This variable indicates whether the participant smokes tobacco in any form, including cigarettes,
pipes, or cigars.
SOURCE
American Heart Association
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
1 Current Smoker
Participant currently smokes tobacco in any form, including
cigarettes, pipes, or cigars
2 Quit (1-12 months ago)
Participant quit smoking tobacco in any form, including cigarettes,
pipes, or cigars, 1 to 12 months ago
3 Quit (More than 12
months ago)
Participant quit smoking tobacco in any form, including cigarettes,
pipes, or cigars, more than 12 months ago
4 Never Smoked
Participant has never smoked tobacco in any form, including
cigarettes, pipes, or cigars
8 Don’t want to answer
Participant does not want to answer whether she smokes tobacco in
any form, including cigarettes, pipes, or cigars
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To identify participants who might benefit from smoking cessation counseling and tobacco cessation
resources (quit line and community-based)
To provide data element required to determine participant’s cardiovascular risk score
36
Item 10a: PHQ
Over the past 2 weeks, how often have you been bothered by any of the following problems?
I.
Little interest or pleasure in doing things (not at all, several days, more than half, or
nearly every day)?
II.
Feeling down, depressed, or hopeless (not at all, several days, more than half, or
nearly every day)?
This variable indicates the number of days during the past two weeks that the participant felt little
interest of pleasure in doing things and felt down, depressed, or hopeless.
SOURCE
Patient Health Questionnaire (PHQ-2)
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
(CODE FOR EACH
ISSUE)
0 Not at all
Participant has not been bothered by this issue at all over the past
two weeks
1 Several days
Participant has been bothered by this issue several days over the
past two weeks
2 More than half
Participant has been bothered by this issue more than half the days
over the past two weeks
3 Nearly every day
Participant has been bothered by this issue nearly every day over the
past two weeks
8 Don’t want to answer
Participant does not want to answer how often she has been
bothered by this issue
This value will be flagged as a quality check
9 No answer recorded
No answer recorded
This value will be flagged as an error
ANALYSIS AND USE
To determine the health status of individual participants and the overall WISEWOMAN population
To provide health status information for cost benefit or cost effectiveness analyses
37
Item 11a: Height
Height
This variable indicates the participant’s height in inches at baseline screening.
SOURCE
American Heart Association
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Height in inches
Up to a two-digit (numeric) value representing the participant’s height
at baseline screening
Height values between 48" and 58" or 74" and 76" will be flagged for
quality checks and program verification. See Appendix B for the
procedure for validating out-of-range values. Any values outside 48"76" will be considered an error
Example: 62" (5 feet, 2 inches) = 62
77 Unable to obtain
Height measurement was attempted, but measurement results were
not obtained. See Appendix B for the procedure for documenting the
reason that the measurement was not obtained
This value will be flagged as an error
88 Client refused
Participant refuses to have her height measurement taken
This value will be flagged as an error
99 No measurement
recorded
Height measurement was not performed
This value will be flagged as an error
ANALYSIS AND USE
To calculate the BMI of WISEWOMAN participants
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score
38
Item 11b: Weight
Weight
This variable indicates the participant’s weight in pounds.
SOURCE
American Heart Association Life’s
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Weight in pounds
Up to a three-digit (numeric) value representing the participant’s
weight
Weight values between 74 and 90 lb or 350 and 460 lb will be flagged
for quality checks and program verification. See Appendix B for the
procedure for validating out-of-range values. Any values outside 74460 lb will be considered an error
Example: 98 lb = 098
777 Unable to obtain
Weight measurement was attempted, but measurement results were
not obtained
This value will be flagged as a quality check. See Appendix B for the
procedure for documenting the reason that the measurement was not
obtained
888 Client refused
Participant refuses to have her weight measurement taken
This value will be flagged as a quality check
999 No measurement
recorded
Weight measurement was not performed
This value will be flagged as an error
ANALYSIS AND USE
To calculate the BMI of WISEWOMAN participants
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score
39
Item 11c: Waist
Waist Circumference
This variable indicates the participant’s waist circumference in inches.
SOURCE
Not applicable; health screening measurement
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Waist Circumference in inches
Up to a two-digit (numeric) value representing the participant’s
waist circumference in inches
Any value outside the valid range (16 – 71 inches) will be
flagged as a quality check
Example: 30 inches = 30
77 Unable to obtain
Waist circumference measurement was attempted, but
measurement results were not obtained
88 Client refused
Participant refuses to have her waist circumference
measurement taken
99 No measurement recorded
Waist circumference measurement was not performed
ANALYSIS AND USE
To determine waist-hip ratio for the participant
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
40
Item 12a: BPDate
Clinical Assessment Date (Office Visit Date)
This variable indicates the date of the office visit or the date of the follow-up assessment for a
particpant.
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Clinical assessment
date/Office visit date
ANALYSIS AND USE
To identify the date of the office visit
To facilitate analysis of changes in blood pressure over time
To calculate other service time frames, including time to rescreening, lifestyle program sessions,
lifestyle program/health coaching follow-up assessment, risk reduction counseling sessions, alert
referrals, and labs
Valid date in MMDDCCYY format
Date of the office visit or the date of the follow-up assessment for a
participant
Example: September 10, 2013 = 09102013
41
Item 12b: SBP
Systolic Blood Pressure
This variable indicates the participant’s systolic blood pressure readings.
SOURCE
Not applicable; health screening measurement
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
(CODE FOR EACH
READING AND IN
THE ORDER TAKEN)
Systolic blood
pressure in
mmHg
A three-digit (numeric) value representing the participant’s systolic blood
pressure in mmHg
Systolic blood pressure values between 230 and 260 mmHg will be flagged for
quality checks and program verification. Values outside 74-260 mmHg will be
flagged as errors. See Appendix B for the procedure for validating out-of-range
values
If a blood pressure measurement was not obtained at the time of the office visit
and obtained at a referral visit within 30 days of the visit, the blood pressure
measurement from the referral should be recorded here
Example: 90 mmHg = 090
777 Unable to
obtain
Systolic blood pressure measurement was attempted, but results were not
obtained due to technical difficulties or errors
See Appendix B for the procedure for documenting the reason that the
measurement could not be obtained
This value will be flagged as an error
888 Client
refused
Participant refuses to have her systolic blood pressure measurement taken
This value will be flagged as an error
999 No
measurement
recorded
Systolic blood pressure measurement was not performed or not recorded
This value will be flagged as an error
ANALYSIS AND USE
To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure,
stroke, and kidney disease
To identify participants who would benefit from lifestyle programs
To identify participants unaware that they have hypertension (high blood pressure) for referral to
medical management
To determine control and management of blood pressure
To identify participants who require further diagnostic evaluation
To identify hypertension (high blood pressure) risk of the WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score
42
Item 12c: DBP
Diastolic Blood Pressure
This variable indicates the participant’s diastolic blood pressure readings.
SOURCE
Not applicable; health screening measurement
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
(CODE FOR EACH
READING AND IN THE
ORDER TAKEN)
Diastolic blood pressure
in mmHg
A three-digit (numeric) value representing the participant’s diastolic
blood pressure in mmHg
Diastolic blood pressure values between 2-12 mmHg or 122-156
mmHg will be flagged for quality checks and program verification.
Values outside 2-156 mmHg will be considered errors. See Appendix
B for the procedure for validating out-of-range values
If a blood pressure measurement was not obtained at the time of the
office visit and obtained at a referral visit within 30 days of the visit,
the blood pressure measurement from the referral should be
recorded here
Example: 85 mmHg = 085
777 Unable to obtain
Diastolic blood pressure measurement was attempted, but results
were not obtained due to technical difficulties or errors
See Appendix B for the procedure for documenting the reason that
the measurement could not be obtained
This value will be flagged as an error
888 Client refused
Participant refuses to have her diastolic blood pressure measurement
taken
This value will be flagged as an error
999 No measurement
recorded
Diastolic blood pressure measurement was not performed or not
recorded
This value will be flagged as an error
ANALYSIS AND USE
To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure,
stroke, and kidney disease
To identify participants who would benefit from lifestyle programs
To identify participants unaware that they have hypertension(high blood pressure) for referral to
medical management
To determine control and management of blood pressure
To identify participants who require further diagnostic evaluation
To identify hypertension (high blood pressure) risk of the WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score
43
Item 13a: Fast
Fasting Status
This variable indicates whether a participant fasted for at least nine hours prior to having blood
drawn for cholesterol or glucose measurements.
SOURCE
Not applicable; health screening measurement
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
1 Yes
Participant fasted for at least nine hours prior to having blood drawn
2 No
Participant did not fast for at least nine hours prior to having blood
drawn
9 No answer recorded
No answer recorded
Provider failed to confirm fasting status or no information is available
from the provider
This value should be marked if 14b: TotChol, 14c: HDL, 14d: LDL,
14e: Trigly, and 14b: Glucose all are equal to 999/9999, 777/7777, or
888/8888
This value will be flagged as a quality check
ANALYSIS AND USE
To facilitate accurate identification of participants who have high cholesterol, borderline high
cholesterol, diabetes, or pre-diabetes
44
Item 14a: TotChol
Total Cholesterol (fasting or nonfasting)
This variable indicates the participant’s total cholesterol level.
SOURCE
Not applicable; health screening measurement
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Total
cholesterol in
mg/dL
A three-digit (numeric) value representing the participant’s total cholesterol in
mg/dL
Total cholesterol values that are between 44 and 60 mg/dL or 400 and 702 mg/dL
will be flagged for quality checks and program verification. Values outside 44-702
will be considered errors. See Appendix B for the procedure for validating out-ofrange values
Example: 90 mg/dL = 090
777
Inadequate
blood sample
Total cholesterol measurement was attempted, but results were not obtained due
to technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture attempts; (2)
insufficient amount of blood, type of test tube; (3) invalid Cholestech readings due
to very high/low values; (4) sample submitted to laboratory, test not done due to
erroneous or missing laboratory request or other paperwork
See Appendix B for the procedure for documenting the reason that the
measurement was not obtained
This value will be flagged as a quality check
888 Client
refused
Participant refuses to have her blood drawn for cholesterol measurements
If the participant refuses to go to the lab, the participant can be considered to have
refused
If the participant does not go to the scheduled lab appointment after follow-up has
been attempted, the participant can be considered to have refused
This value will be flagged as a quality check
999 No
measurement
recorded
No total cholesterol measurement was taken or recorded
This value will be flagged as an error
ANALYSIS AND USE
To identify participants who are unaware that they have high or borderline high cholesterol and need
preventive services or referral to medical management
To determine cholesterol control and management
To assess the percentage of WISEWOMAN participants who have high cholesterol or borderline
high cholesterol
To assess the risk in the WISEWOMAN population for cardiovascular disease
To provide data element required to determine participant’s cardiovascular risk score
45
Item 14b: HDL
HDL Cholesterol (fasting or nonfasting)
This variable indicates the participant’s HDL cholesterol level.
SOURCE
Not applicable; health screening measurement
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
HDL cholesterol
in mg/dL
A three-digit (numeric) value representing the participant’s HDL cholesterol in
mg/dL
HDL cholesterol values that are between 155 and 196 mg/dL will be flagged
for quality checks and program verification. Values outside 007-196 mg/dL will
be considered errors. See Appendix B for the procedure for validating out-ofrange values
Example: 90 mg/dL = 090
777 Inadequate
blood sample
HDL cholesterol measurement was attempted, but results were not obtained
due to technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture attempts;
(2) insufficient amount of blood, type of test tube; (3) invalid Cholestech
readings due to very high/low values;(4) sample submitted to laboratory, test
not done due to erroneous or missing laboratory request or other paperwork
See Appendix B for the procedure for documenting the reason that the
measurement was not obtained
This value will be flagged as a quality check
888 Client
refused
Participant refuses to have her blood drawn for cholesterol measurements
If the participant refuses to go to the lab, the participant can be considered to
have refused
If the participant does not go to the scheduled lab appointment after follow-up
has been attempted, the participant can be considered to have refused
This value will be flagged as a quality check
999 No
measurement
recorded
No HDL cholesterol measurement was taken or recorded
This value will be flagged as an error
ANALYSIS AND USE
To identify participants who are unaware that they have low HDL cholesterol and need preventive
services or referral to medical management
To assess the percentage of WISEWOMAN participants who have high cholesterol or borderline
high cholesterol
To assess the risk of the WISEWOMAN population for cardiovascular disease
To assist in determining cholesterol control and management
46
Item 14c: LDL
SOURCE
DENOMINATOR
POPULATION
VALUES AND
DESCRIPTION
LDL Cholesterol (fasting)
This variable indicates a fasting participant’s fasting LDL cholesterol level.
Not applicable; health screening measurement
The denominator includes all WISEWOMAN participants with a valid baseline screening
LDL
cholesterol in
mg/dL
777
Inadequate
blood sample
888 Client
refused
999 No
measurement
recorded
ANALYSIS AND USE
A three-digit (numeric) value representing a fasting participant’s fasting LDL
cholesterol in mg/dL
LDL cholesterol values that are between 344 and 380 mg/dL will be flagged for
quality checks and program verification. Values outside 020-380 mg/dL will be
considered errors. See Appendix B for the procedure for validating out-of-range
values
For nonfasting participants, any value in this field will be flagged for a quality
check
Example: 90 mg/dL = 090
LDL cholesterol measurement was attempted, but results were not obtained due
to technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture attempts; (2)
insufficient amount of blood, type of test tube; (3) invalid Cholestech readings
due to very high/low values; (4) sample submitted to laboratory, test not done
due to erroneous or missing laboratory request or other paperwork
This response should be used for participants who were confirmed to be fasting,
but their LDL cholesterol was unable to be obtained
For nonfasting participants, This value will be flagged as a quality check because
all nonfasting participants should have their LDL cholesterol coded as ‘999 No
measurement recorded’
Participant refuses to receive a lipid panel that would include LDL measurements
This response should be used for participants who were confirmed to be fasting,
but refused a lipid panel
For nonfasting participants, This value will be flagged as a quality check because
all nonfasting participants should have their LDL cholesterol coded as ‘999 No
measurement recorded’
No LDL cholesterol measurement was taken or recorded
Nonfasting participants should always have this value
To assist in determining cholesterol control and management
47
Item 14d: Trigly
SOURCE
DENOMINATOR
POPULATION
VALUES AND
DESCRIPTION
Triglycerides (fasting)
This variable indicates a fasting participant’s triglycerides measurement.
Not applicable; health screening measurement
The denominator includes all WISEWOMAN participants with a valid baseline screening
Triglycerides
in mg/dL
7777
Inadequate
blood sample
8888 Client
refused
ANALYSIS AND USE
A four-digit (numeric) value representing a fasting participant’s triglycerides
measurement in mg/dL
Triglycerides values values between 1,000 and 3,000 mg/dL will be flagged for
quality checks and program verification. Values outside 0012-3000 mg/dL will be
considered errors. See Appendix B for the procedure for validating out-of-range
values
For nonfasting participants any value in this field will be flagged for a quality check
Example: 90 mg/dL = 0090
Triglycerides measurement was attempted, but results were not obtained due to
technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture attempts; (2)
insufficient amount of blood, type of test tube; (3) invalid Cholestech readings due
to very high/low values; (4) sample submitted to laboratory, test not done due to
erroneous or missing laboratory request or other paperwork
This response should be used for participants who were confirmed to be fasting, but
their triglycerides measurement could not be obtained
For nonfasting participants, This value will be flagged as a quality check because all
nonfasting participants should have their triglycerides measurement coded as ‘9999
No measurement recorded’
Fasting participant refuses to receive a lipid panel that would include triglycerides
measurements
This response should be used for participants who were confirmed to be fasting, but
refused a lipid panel
For nonfasting participants, This value will be flagged as a quality check because all
nonfasting participants should have their triglycerides measurement coded as ‘9999
No measurement recorded’
No triglycerides measurement was taken or recorded
Nonfasting participants should always have this value
9999 No
measurement
recorded
To assist in determining cholesterol control and management
48
Item 15a: Glucose
Glucose (fasting)
This variable indicates the participant’s fasting glucose measurement.
SOURCE
American Heart Association
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Total glucose in mg/dL
Up to a three-digit (numeric) value representing the participant’s
fasting glucose level in mg/dL
Glucose values that are between 037 and 050 mg/dL or 275 and 571
mg/dL will be flagged for quality checks and program verification.
Values outside 037-571 will be considered errors. See Appendix B for
the procedure for validating out-of-range values
Example: 90 mg/dL = 090
777 Inadequate blood
sample
Glucose measurement was attempted, but results were not obtained
due to technical difficulties or errors
See Appendix B for the procedure for documenting the reason that
the measurement was not obtained
This may include issues such as (1) two or more failed venipuncture
attempts; (2) insufficient amount of blood, type of test tube; (3) invalid
Cholestech readings due to very high/low values; (4) sample
submitted to laboratory, test not done due to erroneous or missing
laboratory request or other paperwork
This value will be flagged as a quality check
888 Client refused
Participant refuses to have her blood drawn for glucose
measurements
If the participant refuses to go to the lab, the participant can be
considered to have refused
If the participant does not go to the scheduled lab appointment after
follow-up has been attempted, the participant can be considered to
have refused
999 No measurement
recorded
No glucose measurement was taken or record
Non-fasting participants should always have this value
ANALYSIS AND USE
To identify participants who have pre-diabetes and diabetes
To assist in determining diabetes control and management
To use in conjunction with A1C percentage to accurately assess a participant’s blood glucose
To provide data element required to determine participant’s cardiovascular risk score
To understand the overall rate of diabetes among the WISEWOMAN population
49
Item 15b: A1C
A1C Percentage
This variable indicates the participant’s A1C percentage (if measured).
SOURCE
Not applicable; health screening measurement
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
A1C percentage
Numeric value representing the participant’s A1C percentage. A1C
should be reported to one decimal point
If A1C was measured by another provider within the last 3 months,
it is acceptable to input the value if it is available
A1C values between 02.8% and 04.0% or 13.0% and 16.2% will
be flagged for quality checks and program verification. Values
outside 02.8%-16.2% will be considered errors. See Appendix B
for the procedure for validating out-of-range values
Example: 8.5% = 08.5 (where the decimal place counts as part of
the variable length)
7777 Inadequate blood
sample
A1C measurement was attempted, but results were not obtained
due to technical difficulties or errors
This value will be flagged as a quality check
8888 Client refused
Participant refuses to have an A1C test
If a participant refuses to go to the lab, the participant can be
considered to have refused
If a participant does not go to the scheduled lab appointment after
follow-up has been attempted, the participant can be considered to
have refused
9999 No measurement
recorded
No A1C measurement was taken or recorded
ANALYSIS AND USE
To identify participants who have diabetes and refer them for medical management
To identify participants who have higher-than-optimal A1C levels and would benefit from
preventive services such as lifestyle programs
To assist in determining diabetes control and management
To assess the cardiovascular disease risk factors in the WISEWOMAN population
To provide data element required to determine participant’s cardiovascular risk score
50
Item 16a: BPAlert
Is a medical follow-up for blood pressure reading necessary?
This variable indicates the status of medical follow-up for a participant’s alert level blood pressure.
SOURCE
Not applicable; health screening measurement
DENOMINATOR
POPULATION
Participants who have an alert level blood pressure value are included in the denominator
VALUES AND
DESCRIPTION
1 Medically necessary
Clinical follow-up for blood pressure is medically necessary
2 Not medically needed
Clinical follow-up for blood pressure is not medically necessary
3 Medically necessary
follow-up appointment
declined
Clinical follow-up for blood pressure is medically necessary but
participant declined to attend a follow-up appointment
8 Client refused workup
Participant had an alert level blood pressure reading but refused
workup
9 No answer recorded
No answer recorded. This value will be flagged as an error.
ANALYSIS AND USE
To assess whether participants with alert level blood pressure readings are receiving a workup
To assist in determining hypertension (high blood pressure) management, and control
51
Item 16b: BPDiDate
What is the date of the medically necessary follow-up appointment?
This variable indicates the folliow-up appointment date for a participant with an alert level blood
pressure reading.
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
Participants who have an alert level blood pressure value are included in the denominator
VALUES AND
DESCRIPTION
Medically Necessary
Follow-up Appointment
Date
ANALYSIS AND USE
To assess whether providers are performing timely workups for participants with alert level blood
pressure values
To determine whether programs are meeting the guideline of workups within one week of the
screening for alert participants
To assist in determining hypertension (high blood pressure) prevention, management, and control
Valid date in MMDDCCYY format
If follow-up information is provided for this referral, the workup date
can be entered
Example: September 10, 2013 = 09102013
52
Item 17a: RRCComplete
Risk Reduction Counseling Completion Date
This variable indicates the date that risk reduction counseling was completed.
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Risk reduction
counseling follow-up
date
Valid date in MMDDCCYY format
Date must occur within the submission period
Example: September 10, 2013 = 09102013
88888888 Participant
refused further program
contact
Participant refused further program contact
This value will be flagged as a quality check
99999999 Participant
lost to follow-up
Provider made three attempts to follow-up with participant but
participant lost to follow-up.
This value will be flagged as a quality check
ANALYSIS AND USE
To determine the date of a completed risk reduction counseling session
To facilitate analysis of changes in risk reduction counseling provision over time
53
Item 18a: RefDate
Lifestyle Program (LSP) / Health Coaching (HC) Referral Date
This variable indicates the date that a referral to a LSP/HC occurred.
FORMAT
Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:
Numeric
8
16
Yes
No
Other Format:
Justification:
Beginning Position:
Valid Range:
MMDDCCYY
Right
374
Valid date
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Lifestyle Program/Health
Coaching Referral Date
ANALYSIS AND USE
To determine the date of the referral to a LSP/HC
To assist in determining whether the participant has received a referral to a LSP/HC
To assist in determining the number of LSP/HC referrals per participant
To facilitate analysis of changes in LSP/HC referrals over time
Valid date in MMDDCCYY format
Date must occur within the submission period
Example: September 10, 2013 = 09102013
54
Item 19a: LSPHCRec
Number of Lifestyle Program (LSP) / Health Coaching (HC) Sessions Received by the
Participant During the Screening Cycle
This variable indicates the number of LSP/HC sessions the participant has received during the
current screening cycle.
FORMAT
Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:
Numeric
2
2
Yes
No
Other Format:
Justification:
Beginning Position:
Valid Range:
N/A
Right
390
Cannot be blank if
RefDate is valid
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
The denominator includes all WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Number of Sessions
ANALYSIS AND USE
To track the number of LSP/HC sessions that the participant has received
To assess LSP/HC sessions in context of types and settings, and readiness to change of a
participant
Value representing the number of LSP/HC sessions the participant has
received during the current screening cycle
Example: 6 visits = 06
55
Item 19b: Intervention
Date of Lifestyle Program (LSP) / Health Coaching (HC) Session
For LSP/HC records, this variable indicates the date that the LSP/HC session occurred.
FORMAT
Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:
Numeric
8
128
Yes
No
Other Format:
Justification:
Beginning Position:
Valid Range:
MMDDCCYY
Right
392
Valid date
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
All LSP/HC sessions among WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Lifestyle Program/Health
Coaching Session Date
ANALYSIS AND USE
To determine the date of the LSP/HC session
To assist in determining whether the participant has received an LSP/HC session
To assist in calculating the number of LSP/HC sessions per participant
To assess whether participants with risk factors receive LSP/HC services
To assess changes in risk profile between participants who participate in the LSP/HC and
participants who do not
Valid date in MMDDCCYY format
Date must occur within the submission period
Example: September 10, 2013 = 09102013
56
Item 19c: LSPHCID
Lifestyle Program (LSP) / Health Coaching (HC) ID
This variable indicates which LSP/HC was used.
FORMAT
Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
All LSP/HC sessions among WISEWOMAN participants with a valid baseline screening
VALUES AND
DESCRIPTION
Lifestyle Program ID
Value representing the ID code of the LSP as assigned
Health Coaching ID
Value representing the ID code of the HC as assigned
ANALYSIS AND USE
Character
10
160
N/A
No
Other Format:
Justification:
Beginning Position:
Valid Range:
N/A
Left
520
Valid code for an
LSP/HC; cannot be
blank if a valid date is
provided for Intervention
To track the number of WISEWOMAN participants who receive an LSP/HC session from each
WISEWOMAN LSP/HC provider
To describe differences in participant demographics or other characteristics by LSP/HC provider
To identify the number of LSP/HC providers in a given geographic area
57
Item 20a: TobResDate
Date of Referral to Tobacco Cessation Resource
This variable indicates the date that the referral to a tobacco cessation resource occurred.
FORMAT
Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:
Numeric
8
24
Yes
No
Other Format:
Justification:
Beginning Position:
Valid Range:
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
WISEWOMAN participants with a valid baseline screening wwho identify themselves as current
smokers
VALUES AND
DESCRIPTION
Tobacco Cessation
Resource Referral Date
ANALYSIS AND USE
To document the date of a referral to tobacco cessation resource
To assist in tracking receipt of tobacco cessation resource
Valid date in MMDDCCYY format
Date must occur within the submission period
Example: September 10, 2013 = 09102013
58
MMDDCCYY
Right
776
Valid date; cannot be
blank if RRCSmoke =1
Item 20b: TobResType
Type of Tobacco Cessation Resource
This variable indicates the type of tobacco cessation resource that the participant was referred to.
FORMAT
Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
WISEWOMAN participants with a valid baseline screening who identify themselves as current
smokers
VALUES AND
DESCRIPTION
1 Quit line
Participant was referred to a proactive tobacco quit line
2 Community-based tobacco
program
Participant was referred to a community-based tobacco
program
3 Other tobacco cessation
resources
Participant was referred to other tobacco cessation
resources
9 No answer recorded
No answer was recorded
This value will be flagged as an error if a valid date is
provided for TobResDate
ANALYSIS AND USE
Numeric
1
3
No
No
Other Format:
Justification:
Beginning Position:
Valid Range:
N/A
Right
800
See values; cannot be
blank if valid date is
provided for
TobResDate
To determine the number of smokers that received a referral to tobacco cessation resource
To determine how frequently different types of tobacco cessation resources are being used within
and across programs
To compare the smoking status at rescreening and follow-up of women who were linked to tobacco
cessation resources versus those who were not
59
Item 20c: TResComp
Tobacco Cessation Activity Completed
This variable indicates whether the participant completed tobacco cessation activity.
FORMAT
Type:
Item Length:
Field Length:
Leading Zeros:
Static Field:
SOURCE
Not applicable; WISEWOMAN-specific variable
DENOMINATOR
POPULATION
WISEWOMAN participants with a valid baseline screening who identify themselves as current
smokers
VALUES AND
DESCRIPTION
1 Yes – Completed tobacco
cessation activity
Participant completed tobacco cessation activity
2 No – Partially completed
tobacco cessation activity
Participant partially completed tobacco cessation activity
3 No – Discontinued from tobacco
cessation activity when reached
Participant decided to discontinue from tobacco cessation
counseling when contacted by the tobacco cessation
resource
4 No – Could not reach to conduct
tobacco cessation activity
Participant could not be reached when contacted by the
tobacco cessation resource
9 No answer recorded
No answer was recorded
This value will be flagged as an error if a valid date is
provided for TobResDate
ANALYSIS AND USE
Numeric
1
3
No
No
Other Format:
Justification:
Beginning Position:
Valid Range:
N/A
Right
803
See values; cannot be
blank if valid date is
provided for
TobResDate
To determine the number of smokers that participated in tobacco cessation activities
To compare the smoking status at rescreening and follow-up of women who were linked to tobacco
cessation resources versus those who were not
60
| File Type | application/pdf |
| File Title | WISEWOMAN Program MDE Manual Version 9.04 |
| Subject | This WISEWOMAN MDE Manual was written to provide guidance on the collection and submission of minimum data elements (MDEs) for t |
| Author | CDC;WISEWOMAN |
| File Modified | 2018-06-20 |
| File Created | 2018-06-20 |